Published in Drug Week, February 24th, 2006
In October 2005, Armstrong was appointed to serve as interim CEO and president commencing January 1, 2006.
Prior to joining Genaera, Armstrong served as CEO of Mills Biopharmaceuticals, a subsidiary of UroCor, Inc., and as vice president of business development at UroCor. Armstrong was also president and COO at Oread, Inc., a fully integrated contract research organization.
"This is an exciting time to lead Genaera," said Armstrong. "We have four promising products in clinical development,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.